CD8A and COVID-19: On the contrary, 47% of individuals with critical COVID-19 were homozygous for HLA-C2 alleles, which are more unstable and could be associated to a poorer disease prognosis due to their lower efficiency to present SARS-CoV-2 peptides to CD8+ T cells and/or activate NK cells.